UK drugmaker in China bribery probe

GlaxoSmithKline's British and Chinese executives accused of paying off health institutions to use their pricey products.

    Police in China have completed an investigation into a suspected bribery case involving the multinational pharmaceutical company GlaxoSmithKline (GSK) and handed it over to prosecutors on Wednesday.

    After an almost year-long investigation, police alleged that William Mark Reilly, a British national and executive of GSK China, and two Chinese executives, Zhang Guowei and Zhao Hongyan, bribed Chinese hospitals, doctors and health institutions, to use their products.

    The drugmaker GSK China used illegal means to maximise profit, its former employees alleged.

    Al Jazeera's Tim Friend reports from London.

    SOURCE: Al Jazeera


    YOU MIGHT ALSO LIKE

    Why Saudi-Israeli normalisation could be dangerous

    Why Saudi-Israeli normalisation could be dangerous

    Apart from being disastrous for Palestine, normalising relations with Israel could get Saudi Arabia in real trouble.

    Gender violence in India: 'Daughters are not a burden'

    Gender violence in India: 'Daughters are not a burden'

    With female foeticide still widespread, one woman tells her story of being mutilated for giving birth to her daughters.

    What is Mohammed bin Salman's next move?

    What is Mohammed bin Salman's next move?

    There are reports Saudi Arabia is demanding money from the senior officials it recently arrested.